Patents Assigned to Nanovault Medical, LLC
  • Implantable cellular and biotherapeutic agent delivery canister
    Patent number: 11857673
    Abstract: A material includes a metallic, nanoporous structure having a plurality of nanopores having a porosity that allows passage of insulin but not IgG. The metallic nanoporous structure includes titanium, 316L stainless steel and may have a textured nano-sericeous surface. A nanoporous bicontinuous structure can be integrated with nanopores.
    Type: Grant
    Filed: October 24, 2022
    Date of Patent: January 2, 2024
    Assignee: NanoVault Medical, LLC
    Inventors: Willard W. Hennemann, Bryan L. Steelman, Thomas J. Webster, Janet E. Davis
  • Implantable cellular and biotherapeutic agent delivery canister
    Patent number: 11857672
    Abstract: The invention relates to a metallic, nanoporous canister used to encapsulate cellular and/or biotherapeutic agents. The device is biocompatible and functions to wholly isolate a therapeutically active agent and/or cells therein. Their implantation, and survival in vivo, permits the local or systemic diffusion of their encapsulated cellular and/or biomolecular and therapeutics factors with the potential to promote repair of damaged or degenerated tissues in mammalian hosts, primarily humans.
    Type: Grant
    Filed: January 26, 2022
    Date of Patent: January 2, 2024
    Assignee: NanoVault Medical, LLC
    Inventors: Willard W. Hennemann, Bryan L. Steelman, Thomas J. Webster, Janet E. Davis
  • Implantable cellular and biotherapeutic agent delivery canister
    Patent number: 11857670
    Abstract: The invention relates to a metallic, nanoporous canister used to encapsulate cellular and/or biotherapeutic agents. The device is biocompatible and functions to wholly isolate a therapeutically active agent and/or cells therein. Their implantation, and survival in vivo, permits the local or systemic diffusion of their encapsulated cellular and/or biomolecular and therapeutics factors with the potential to promote repair of damaged or degenerated tissues in mammalian hosts, primarily humans.
    Type: Grant
    Filed: August 5, 2020
    Date of Patent: January 2, 2024
    Assignee: NanoVault Medical, LLC
    Inventors: Willard W. Hennemann, Bryan L. Steelman, Thomas J. Webster, Janet E. Davis
  • Implantable cellular and biotherapeutic agent delivery canister
    Patent number: 10751280
    Abstract: The invention relates to a metallic, nanoporous canister used to encapsulate cellular and/or biotherapeutic agents. The device is biocompatible and functions to wholly isolate a therapeutically active agent and/or cells therein. Their implantation, and survival in vivo, permits the local or systemic diffusion of their encapsulated cellular and/or biomolecular and therapeutics factors with the potential to promote repair of damaged or degenerated tissues in mammalian hosts, primarily humans.
    Type: Grant
    Filed: September 12, 2018
    Date of Patent: August 25, 2020
    Assignee: NanoVault Medical LLC
    Inventors: Willard W. Hennemann, Bryan L. Steelman, Thomas J. Webster
  • Implantable cellular and biotherapeutic agent delivery canister
    Patent number: 10092507
    Abstract: The invention relates to a metallic, nanoporous canister used to encapsulate cellular and/or biotherapeutic agents. The device is biocompatible and functions to wholly isolate a therapeutically active agent and/or cells therein. Their implantation, and survival in vivo, permits the local or systemic diffusion of their encapsulated cellular and/or biomolecular and therapeutics factors with the potential to promote repair of damaged or degenerated tissues in mammalian hosts, primarily humans.
    Type: Grant
    Filed: June 6, 2015
    Date of Patent: October 9, 2018
    Assignee: NanoVault Medical LLC
    Inventors: Willard W. Hennemann, Bryan L. Steelman, Thomas J. Webster
  • IMPLANTABLE CELLULAR AND BIOTHERAPEUTIC AGENT DELIVERY CANISTER
    Publication number: 20170319472
    Abstract: The invention relates to a metallic, nanoporous canister used to encapsulate cellular and/or biotherapeutic agents. The device is biocompatible and functions to wholly isolate a therapeutically active agent and/or cells therein. Their implantation, and survival in vivo, permits the local or systemic diffusion of their encapsulated cellular and/or biomolecular and therapeutics factors with the potential to promote repair of damaged or degenerated tissues in mammalian hosts, primarily humans.
    Type: Application
    Filed: June 6, 2015
    Publication date: November 9, 2017
    Applicant: Nanovault Medical, LLC
    Inventors: Willard W. Hennemann, Bryan L. Steelman, Thomas J. Webster